openPR Logo
Press release

Diabetic Retinopathy Market: Upcoming Demands and Growth Analysis

08-14-2017 12:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

Diabetic Retinopathy Market

Diabetic Retinopathy Market

Diabetes is a lifelong chronic disease caused by excessive levels of glucose in the blood mainly due to lack or insufficiency of insulin hormone to metabolize the glucose in the blood. This accumulated glucose level in the blood does not reach body cells and severely affects multiple organs such as kidneys, eyes, nerves, blood vessels, and heart. Diabetic Retinopathy is one of the common diabetic eye diseases characterized by the damaged blood vessels in the retina. The damaged blood vessels and nerves lead to blurring of vision, vision impairment, and eye hemorrhage. If left untreated, it may lead to retinal detachment and blindness. Non Proliferative Diabetic Retinopathy (NDPR) and Proliferative Diabetic Retinopathy (PDR) are the two stages of diabetic retinopathy. Diabetic retinopathy can be treated through medicines, laser surgery, and vitrectomy. Diabetic retinopathy can develop in any individual suffering from type 1 or type 2 diabetes. This disease is the leading cause of blindness in the U.S.

Increase in prevalence of diabetes across the globe is anticipated to drive the diabetic retinopathy market. According to National Center for Biotechnology Information, 126 million people were affected by diabetic retinopathy in 2010; more than 191 people are likely to be affected by Diabetic retinopathy by 2030. According to the American National Health and Nutrition Examination Survey conducted between 2005 and 2008, 28.5% of diabetic patients had some degree of DR, while 4.4% of patients suffered from vision threatening diabetic retinopathy. Increase in geriatric population, high prevalence of obesity, and rise in sedentary lifestyle are the key factors driving the global diabetic retinopathy market. Furthermore, increase in awareness about the early detection of Diabetic retinopathy among diabetic patients across the globe, rise in healthcare facilities in emerging and developed countries, and availability of multiple treatment options with advanced technology are the factors propelling the market. However, negligence of Diabetic retinopathy, poor planning of Diabetic retinopathy treatment in low income countries, and lack of skilled professionals for treatment of Diabetic retinopathy in emerging and less developed countries are the key restraining factors of the market.

This report gives readers a comprehensive overview of the Diabetic Retinopathy Market: http://www.transparencymarketresearch.com/diabetic-retinopathy-market.html

The global diabetic retinopathy market can be segmented based on stages of diabetic retinopathy, type of treatment, end-user, and region. There are primarily two stages of diabetic retinopathy: Non proliferative diabetic retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is early stage of Diabetic retinopathy characterized by the leakage of blood vessels, resulting in deposition of blood and blood components in retina. PDR is the advanced stage of Diabetic retinopathy characterized by abnormal growth of blood vessel, which results in swelling of retina called Diabetic Macular Edema (DME). Diabtetic retinopathy can be treated and controlled through injections of Vascular Endothelial Growth Factor (VEGF), laser treatments, and vitrectomy. Laser treatment is further classified into focal laser treatment and scattered laser treatment.

In terms of geography, the global diabetic retinopathy market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market during the forecast period owing to the rise in prevalence of diabetic retinopathy patients in the region, increase in healthcare infrastructure, and growth in awareness about Diabetic retinopathy among diabetic patients. Asia Pacific is estimated to follow North America, led by the increase in diabetic population and changing lifestyle of people in the region. Asia Pacific is expected to maintain the highest growth rate during the forecast period. Middle East & Africa is projected to be the least attractive market primarily due to the presence of low income groups, lack of skilled professionals, and poor accessibility to healthcare facilities in the region.

Get accurate market forecast and analysis on the Diabetic Retinopathy Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22910

Key players operating in the global diabetic retinopathy market are ThromboGenics N.V., F. Hoffmann-La Roche Ltd, Bayer AG, Novartis AG., Allergan Inc., Abbott Laboratories Inc., Pfizer Inc., and Valeant Pharmaceutical International, Inc. New business development through acquisitions and mergers, and establishment of subsidiaries in emerging economies are some of the common trends observed in the global diabetic retinopathy market.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Retinopathy Market: Upcoming Demands and Growth Analysis here

News-ID: 667964 • Views: 87

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Diabetic

Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282 Global Diabetic Socks Market: Factors Impacting the Market The primary factors driving the growth of the global diabetic socks market are increasing
Expanding Diabetic Populace Driven Growth For Diabetic Food Market Globally
Market Overview Diabetic Food items are dietary items that incorporate diminished starch and sugar substance that assistance in controlling the ascent of the blood glucose. Diabetic Food additionally contains low calorie sweeteners, slim down refreshments, and so on. These items are devoured by diabetic individuals and by the general population who are not diabetic as careful step to avoid diabetes. Diabetic nourishment makers are entering into different market fragments by presenting
Diabetic Alcohol Swabs Market
An alcohol swab is gauze that has been dipped and saturated with alcohol. It is a vital part of any first aid kit. Alcohol swabs are primarily used to disinfect and clean cuts and scrapes. They are used in doctors’ clinics, diagnostic centers, and other places where quick and easy cleaning of a locale is desired. The alcohol in the alcohol swabs helps get rid of possible sources of contamination
Global Diabetic Retinopathy Market
The Diabetic Retinopathy Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes diabetes. Globally, the incidence of diabetes is
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be
Diabetic Food: Global Markets
Diabetic Food Market (Ice Creams & Jellies, Dairy Products, Dietary Beverages, Baked Products, Confectionary, Snacks and Other Products): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 The report provides historic data of 2015 and forecast from 2016 to 2021 based on revenue (USD Billion) The report gives the overview of the diabetic food industry along with the forecast and analysis for the diabetic food market